Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 73.29

+2.5%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John who wrote (2423)	1/6/1999 12:13:00 AM
From: synchro	Read Replies (1) of 4676

I am reminded of Immunex a couple years back. If memory serves me, I remember the stock was at $12 a share and American Home Products offered to buy them out at $15. At that time I was actually pretty happy to take the offer, but thank goodness Immunex management has the good sense and judgement to reject the offer. At that time if you tell me IMNX will be at $125, I would have told you you are inhaling something. Well, lo and behold.... So now again I have a small position in Isis. The lesson I get from my previous experience is that there will be plenty of opportunity to buy Isis on the way up if this company is going to amount to something in the future. There will be plenty of institutional buying power as Isis _earns_ (not hype) its credibility with real results. They now have a niche drug just approved, let's see if their antisense technology can follow up with something else. The current updraft appears to be a general revaluation of the biotech sector, not anything specific to Isis. So just as the updraft is sudden, so can be the downdraft. Just my 2c

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next